Log on / register
Feedback | Support | My details
Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779.
Messina MP, Rauktys A, Lee L, Dabora SL
BMC Pharmacol 2007, 7:14
[Full text] [PubMed] [Related articles]


No citations for this article were found in PubMed Central.

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.